Ahmid, M, Perry, C G, Ahmed, S F & Shaikh, M G. (2016). Growth hormone deficiency during young adulthood and the benefits of growth hormone replacement. Endocr Connect 5, R1–R11.
Barkan, A L, DeMott-Friberg, R & Samuels, M H. (2000). Growth hormone (GH) secretion in primary adrenal insufficiency: effects of cortisol withdrawal and patterned replacement on GH pulsatility and circadian rhythmicity. Pituitary 3, 175–179.
Bartke, A, List, E O & Kopchick, J J. (2016). The somatotropic axis and aging: benefits of endocrine defects. Growth hormone IGF Res 27, 41–45.
Baumann, G P. (2012). Growth hormone doping in sports: a critical review of use and detection strategies. Endocr Revs 33, 155–186.
Ben-Shlomo, A & Melmed, S. (2010). Pituitary somatostatin receptor signaling. Trends Endocr Metab 21, 123–133.
Berardelli, R, Margarito, E, Ghiggia, F et al. (2010). Neuroendocrine effects of citalopram, a selective serotonin re-uptake inhibitor, during lifespan in humans. J Endocrinol Invest 33, 657–662.
Bhansali, A, Velayutham, P, Sialy, R & Sethi, B. (2005). Effect of opiates on growth hormone secretion in acromegaly. Horm Metab Res 37, 425–427
Bivens, C H, Lebovitz, H E & Feldman, J M. (1973). Inhibition of hypoglycemia-induced growth hormone secretion by the serotonin antagonists cyproheptadine and methysergide. New Engl J Med 289, 236–239.
Blackman, M R. (2000). Age-related alterations in sleep quality and neuroendocrine function; interrelationships and implications. JAMA 284, 879–881.
Brandenberger, G & Weibel, L. (2004). The 24-h growth hormone rhythm in men: sleep and circadian influences questioned. J Sleep Res 13, 251–255.
Casanueva, F F, Villanueva, L, Cabranes, J A, Cabezas-Cerrato, J & Fernandez-Cruz, A. (1984). Cholinergic mediation of growth hormone secretion elicited by arginine, clonidine, and physical exercise in man. J Clin Endocr Metab 59, 526–530.
Caufriez, A, Leproult, R, L’Hermite-Baleriaux, M, Moreno-Reyes, R & Copinschi, G. (2009). A potential role of endogenous progesterone in modulation of GH, prolactin and thyrotrophin secretion during normal menstrual cycle. Clin Endocr, 71, 535–542.
Chertman, L S, Merriam, G R & Kargi, A Y. (2015). Growth hormone in aging. www.endotext.org
Christoforidis, A, Maniadaki, I & Stanhope, R. (2005). Growth hormone/insulin-like growth factor axis during puberty. Ped Endocr Rev 1, 5–10.
Deltondo, J, Por, I, Hu, W et al. (2008). Associations between the human growth hormone-releasing hormone- and neuropeptide-y-immunoreactive systems in the human diencephalon: a possible morphological substrate of the impact of stress on growth Neurosci 153, 1146–1152.
Donjacour, C E H M, Aziz, N A, Roelfsema, F et al. (2011). Effect of sodium oxybate on growth hormone secretion in narcolepsy patients and healthy controls. Am J Physiol Endocr Metab 300, E1069–E1075.
Eigler, T & Ben-Shlomo, A. (2014). Somatostatin system: molecular mechanisms regulating anterior pituitary hormones. J Mol Endocr 53, R1–R19.
Fanciulli, G, Delitala, A & Delitala, G. (2009). Growth hormone, menopause and ageing: no definite evidence for ‘rejuvenation’ with growth hormone. Hum Reprod Update 15, 341–358.
Fedi, M, Bach, L A, Berkovic, S F, Willoughby, J O, Scheffer, I E & Reutens, D C. (2008). Association of a nicotinic receptor mutation with reduced height and blunted physostigmine-stimulated growth hormone release. J Clin Endocr Metab 93, 634–637.
Franck, S E, Muhammad, A, van der Lely, A J & Neggers, S J. (2016).Combined treatment of somatostatin analogues with pegvisomant in acromegaly. Endocr 52, 206–213.
Giusti, M, Delitala, G, Marini, G et al. (1992). The effect of a met-enkephalin analogue on growth hormone, prolactin, gonadotropins, cortisol and thyroid stimulating hormone in healthy elderly men. Acta Endocrinol 127, 205–209.
Giustina, A & Veldhuis, J D. (1998). Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human. Endocr Revs 19, 717–797.
Giustina, A, Romanelli, G, Candrina, R & Giustina, G. (1989). Growth hormone deficiency in patients with idiopathic adrenocorticotropin deficiency resolves during glucocorticoid replacement. J Clin Endocr Metab 68, 120–124.
Giustina, A, Scalvini, T, Tassi, C et al. (1997). Maturation of the regulation of growth hormone secretion in young males with hypogonadotropic hypogonadism pharmacologically exposed to progressive increments in serum testosterone. J Clin Endocr Metab 82, 1210–1219.
Goldenberg, N & Barkan, A. (2007). Factors regulating growth hormone secretion in humans. Endocr Metab Clin N Amer 36, 37–55.
Guevara-Aguirre, J, Balasubramanian, P, Guevara-Aguirre, M et al. (2011). Growth hormone receptor deficiency is associated with a major reduction in pro-aging signaling, cancer, and diabetes in humans. Sci Transl Med 3, 70ra13.
Guevara-Aguirre, J & Rosenbloom, A L. (2015). Obesity, diabetes and cancer: insight into the relationship from a cohort with growth hormone receptor deficiency. Diabetologia 58, 37–42.
Heaney, A P & Melmed, S. (2004). Molecular targets in pituitary tumours. Nature Revs Cancer 4, 285–295.
Imran, S A, Aldahmani, K A, Penney, L et al. (2018). Unusual AIP mutation and phenocopy in the family of a young patient with acromegalic gigantism. Endocr Diabetes Metab Case Rep 2018, 17–0092.
Junnila, R K, List, E O, Berryman, D E, Murrey, J W & Kopchick, J J. (2013). The GH/IGF-1 axis in ageing and longevity. Nat Rev Endocr 9, 366–376.
Kalleinen, N, Polo-Kantola, P, Irjala, K et al. (2008). 24-hour serum levels of growth hormone, prolactin, and cortisol in pre- and postmenopausal women: the effect of combined estrogen and progestin treatment. J Clin Endocr Metab 93, 1655–1661.
Kaplan, S L, Grumbach, M M & Aubert, M L. (1976). The ontogenesis of pituitary hormones and hypothalamic factors in the human fetus: maturation of central nervous system regulation of anterior pituitary function. Rec Prog Horm Res 32, 161–243.
Kargi, A Y & Merriam, G R. (2013). Diagnosis and treatment of growth hormone deficiency in adults. Nat Rev Endocr 9, 335–345.
Latta, F, Leproult, R, Tasali, E et al. (2005). Sex differences in nocturnal growth hormone and prolactin secretion in healthy older adults: relationships with sleep EEG variables. Sleep 28, 1519–1524.
Lim, C T, Grossman, A & Khoo, B. (2014). Normal physiology of ACTH and GH release in the hypothalamus and anterior pituitary in man. www.endotext.org
Mann, K, Rossbach, W, Müller, M J et al. (2006). Nocturnal hormone profiles in patients with schizophrenia treated with olanzapine. Psychoneuroendocrinol 31, 256–264.
Mazziotti, G & Giustina, A. (2013). Glucocorticoids and the regulation of growth hormone secretion. Trends Endocr Metab 9, 265–276.
Meinhardt, U J & Ho, K K Y. (2006). Modulation of growth hormone action by sex steroids. Clin Endocr 65, 413–422.
Melmed, S. (2016). New therapeutic agents for acromegaly. Nat Revs Endocr 12, 90–98.
Miller, J D, Esparza, A, Wright, N M et al. (1993). Spontaneous growth hormone release in term infants: changes during the first four days of life. J Clin Endocr Metab 76, 1058–1062.
Milman, S, Huffman, D M & Barzilai, N. (2016). The somatotropic axis in human aging: framework for the current state of knowledge and future research. Cell Metab 23, 980–989.
Nass, R, Gaylinn, B D & Thorner, M O. (2011). The role of ghrelin in GH secretion and GH disorders. Mol Cell Endocr 340, 10–14.
Norman, C, Rollene, N, Weist, S M et al. (2014a). Short-term estradiol supplementation potentiates low-dose ghrelin action in the presence of GHRH or somatostatin in older women. J Clin Endocr Metab 99, E73–E80.
Norman, C, Rollene, N L, Erickson, D, Miles, J M, Bowers, C Y & Veldhuis, J D. (2014b). Estradiol regulates GH releasing-peptide’s interactions with GH-releasing hormone and somatostatin in postmenopausal women. Eur J Endocr 170, 121–129.
Obermayr, R P, Mayerhofer, L, Knechtelsdorfer, M et al. (2005). The age-related down-regulation of the growth hormone/insulin-like growth factor-1 axis in the elderly male is reversed considerably by donepezil, a drug for Alzheimer’s disease. Exp Gerontol 40, 157–163.
Ocampo-Lim, B, Guo, W, DeMott-Friberg, R, Barkan, A L & Jaffe, C A. (1996). Nocturnal growth hormone (GH) secretion is eliminated by infusion of GH-releasing hormone antagonist. J Clin Endocr Metab 81, 4396–4399.
Olsen, J, Peroski, M, Kiczek, M, Grignol, G, Merchenthaler, I & Dudas, B. (2014). Intimate associations between the endogenous opiate systems and the growth hormone-releasing hormone system in the human hypothalamus. Neurosci 258, 238–245.
Orio, F Jr., Palombab, S, Colao, A et al. (2001). Growth hormone secretion after baclofen administration in different phases of the menstrual cycle in healthy women. Horm Res 55, 131–136.
Peroski, M, Proudan, N, Grignol, G, Merchenthaler, I & Dudas, B. (2016). Corticotropin-releasing hormone (CRH)-immunoreactive (IR) axon varicosities target a subset of growth hormone-releasing hormone (GHRH)-IR neurons in the human hypothalamus. J Chem Neuroanat 78, 119–124.
Proudan, N, Peroski, M, Grignol, G, Merchenthaler, I & Dudas, B. (2015). Juxtapositions between the somatostatinergic and growth hormone-releasing hormone (GHRH) neurons in the human hypothalamus. Neurosci 297, 205–210.
Reiter, E O & Rosenfeld, R G. (2008). Normal and aberrant growth. Williams Textbook of Endocrinology, 11th Edition (New York: Saunders Elsevier), 849–968.
Ren, S-G, Taylor, J, Dong, J, Yu, R, Culler, M D & Melmed, S. (2003). Functional association of somatostatin receptor subtypes 2 and 5 in inhibiting human growth hormone secretion. J Clin Endocr Metab 88, 4239–4245.
Roelfsema, F & Veldhuis, J D. (2016). Growth hormone dynamics in healthy adults are related to age and sex and strongly dependent on body mass index. Neuroendocr 103, 335–344.
Rotoli, G, Grignol, G, Hu, W, Merchenthaler, I & Dudas, B. (2011). Catecholaminergic axonal varicosities appear to innervate growth hormone-releasing hormone-immunoreactive neurons in the human hypothalamus: the possible morphological substrate of the stress-suppressed growth. J Clin Endocr Metab 96, E1606–E1611.
Rozario, K, Lloyd, C & Ryan, F J. (2015). GH and IGF-1 physiology in childhood. www.endotext.org
Sattler, F R. (2013). Growth hormone in the aging male. Best Pract Res Clin Endocr Metab 27, 541–555.
Schmid, H A, Brue, T, Colao, A et al. (2016). Effect of pasireotide on glucose- and growth hormone-related biomarkers in patients with inadequately controlled acromegaly. Endocr 53, 210–219.
Schüle, C, Baghai, T, Schmidbauer, S, Bidlingmaier, M, Strasburger, C J & Laakmann, G. (2004). Reboxetine acutely stimulates cortisol, ACTH, growth hormone and prolactin secretion in healthy male subjects. Psychoneuroendocr 29, 185–200.
Schüssler, P, Uhr, M, Ising, M et al. (2006). Nocturnal ghrelin, ACTH, GH and cortisol secretion after sleep deprivation in humans. Psychoneuroendocr 31, 915–923.
Schwartz, M W, Woods, S C, Porte, D, Jr., Seeley, R J & Baskin, D G. (2000). Central nervous system control of food intake. Nature 404, 661–671.
Scratch, S E, Anderson, P J, Doyle, L W et al. (2015). High postnatal growth hormone levels are related to cognitive deficits in a group of children born very preterm. J Clin Endocr Metab 100, 2709–2717.
Shimon, I & Barkan, A. (2012). Estrogen treatment for acromegaly. Pituitary 15, 601–607.
Steyn, F J, Tolle, V, Chen, C & Epelbaum, J. (2016). Neuroendocrine regulation of growth hormone secretion. Compr Physiol 6, 687–735.
Theodoropoulou, M & Stalla, G K. (2013). Somatostatin receptors: from signaling to clinical practice. Front Neuroendocr 34, 228–252.
Thomas, G B, Cummins, J T, Francis, H, Sudbury, A W, McCloud, P I & Clarke, I J. (1991). Effect of restricted feeding on the relationship between hypophysial portal concentrations of growth hormone (GH)-releasing factor and somatostatin, and jugular concentrations of GH in ovariectomized ewes. Endocr 128, 1151–1158.
Van Cauter, E, Plat, L, Scharf, M B et al. (1997). Simultaneous stimulation of slow-wave sleep and growth hormone secretion by gamma-hydroxybutyrate in normal young men. J Clin Invest 100, 745–753.
Van Cauter, E, Plat, L & Copinschi, G. (1998). Interrelations between sleep and the somatotropic axis. Sleep 21, 553–566.
Van Cauter, E, Leproult, R & Plat, L. (2000). Age-related changes in slow wave sleep and REM sleep and relationship with growth hormone and cortisol levels in healthy men. JAMA 284, 861–868.
Van Cauter, E, Latta, F, Nedeltcheva, A et al. (2004). Reciprocal interactions between the GH axis and sleep. Growth Hormone & IGF Res 14, S10–S17.
Veldhuis, J D, Metzger, D L, Martha, P M Jr. et al. (1997). Estrogen and testosterone, but not a nonaromatizable androgen, direct network integration of the hypothalamo-somatotrope (growth hormone)– insulin-like growth factor I axis in the human: evidence from pubertal pathophysiology and sex-steroid hormone replacement. J Clin Endocr Metab 82, 3414–3420.
Veldhuis, J D, Keenan, D M, Mielke, K, Miles, J M & Bowers, C Y. (2005). Testosterone supplementation in healthy older men drives GH and IGF-I secretion without potentiating peptidyl secretagogue efficacy. Europ J Endocr 153, 577–586.
Veldhuis, J D, Roemmich, J N, Richmond, E J & Bowers, C Y. (2006). Somatotropic and gonadotropic axes linkages in infancy, childhood, and the puberty-adult transition. Endocr Revs 27, 101–140.
Veldhuis, J D, Reynolds, G A, Iranmanesh, A & Bowers, C Y. (2008). Twenty-four hour continuous ghrelin infusion augments physiologically pulsatile, nycthemeral, and entropic (feedback-regulated) modes of growth hormone secretion. J Clin Endocr Metab 93, 3597–3603.
Veldhuis, J D, Roelfsema, F, Keenan, D M & Pincus, S. (2011). Gender, age, body mass index, and igf-i individually and jointly determine distinct GH dynamics: analyses in one hundred healthy adults. J Clin Endocr Metab 96, 115–121.
Villa, P, Valle, D, De Marinis, L et al. (1997). Influence of chronic naltrexone treatment on growth hormone secretion in normal subjects. Eur J Endocrinol 137, 631–634.
Vuong, C, Van Uum, S H M, O’Dell, L E, Lutfy, K & Friedman, T C. (2010). The Effects of opioids and opioid analogs on animal and human endocrine systems. Endocr Rev 31, 98–132.
Weikel, J C, Wichniak, A, Ising, M et al. (2003). Ghrelin promotes slow-wave sleep in humans. Am J Physiol Endocr Metab 284, E407–E415.
Weissberger, A J & Ho, K K. (1993). Activation of the somatotropic axis by testosterone in adult males: evidence for the role of aromatization. J Clin Endocr Metab 76, 1407–1412.